Bothamley G H, Rowan J P, Griffiths C J, Beeks M, McDonald M, Beasley E, van den Bosch C, Feder G
East London Tuberculosis Service, Department of Respiratory Medicine, Homerton Hospital, London E9 6SR, UK.
Thorax. 2002 Jan;57(1):45-9. doi: 10.1136/thorax.57.1.45.
Tuberculosis is increasing in London, especially in those recently entering the UK from an area of high incidence. Screening through the port of arrival scheme has a poor yield and has been considered discriminatory.
A study was undertaken to compare the yield and costs of screening new entrants in a hospital based new entrants' clinic (1262 referrals from the port of arrival), general practice (1311 new registrations), and centres for the homeless (267 individuals) using a symptom questionnaire and tuberculin testing if indicated. Clinical outcome measures were cases of tuberculosis, tuberculin reactors requiring chemoprophylaxis and BCG vaccinations. Cost outcomes were cost per individual screened and cost per individual per case of tuberculosis prevented.
Verbal screening limited tuberculin testing to 16% of those in general practice; most were tested at the other two locations. Intervention (BCG vaccination, chemoprophylaxis or treatment) occurred in 27% of those who received tuberculin testing. Attendance for screening was 17% of the port of arrival notifications (63% had registered with a GP), 54% in primary care, and 67% in the homeless (42% registered with a GP). Costs for screening an individual in general practice, hostels for the homeless, and the new entrants' clinic were 1.26 pounds sterling, 13.17 pounds sterling and 96.36 pounds sterling, respectively, while the cost per person screened per case of tuberculosis prevented was 6.32 pounds sterling, 23.00 pounds sterling, and 10.00 pounds sterling, respectively. The benefit of screening was highly sensitive to the number of cases of tuberculosis identified and case holding during treatment.
Screening for tuberculosis in primary care is feasible and could replace hospital screening of new arrivals for those registered with a GP.
伦敦的结核病发病率正在上升,尤其是在那些最近从高发病率地区进入英国的人群中。通过抵达口岸筛查计划进行的筛查效果不佳,且被认为具有歧视性。
开展了一项研究,比较在医院新设的新入者诊所(来自抵达口岸的1262份转诊)、全科医疗(1311例新登记)和无家可归者中心(267人)中,使用症状问卷并在必要时进行结核菌素检测,对新入者进行筛查的效果和成本。临床结局指标为结核病病例、需要进行化学预防的结核菌素反应者以及卡介苗接种情况。成本结局指标为每名接受筛查者的成本以及每预防一例结核病的人均成本。
口头筛查使全科医疗中接受结核菌素检测的人数仅占16%;大多数人在其他两个地点接受检测。接受结核菌素检测的人群中,有27%接受了干预(卡介苗接种、化学预防或治疗)。筛查的参与率在来自抵达口岸通知者中为17%(63%已在全科医生处登记),在初级医疗中为54%,在无家可归者中为67%(42%已在全科医生处登记)。在全科医疗、无家可归者收容所和新入者诊所中,筛查一名个体的成本分别为1.26英镑、13.17英镑和96.36英镑,而每预防一例结核病的人均筛查成本分别为6.32英镑、23.00英镑和10.00英镑。筛查的益处对确诊的结核病病例数以及治疗期间的病例留存情况高度敏感。
在初级医疗中筛查结核病是可行的,对于已在全科医生处登记的人群,可取代对新入者的医院筛查。